{"name":"Michael Marchand, MD","slug":"michael-marchand-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Hyaluronic acid 0.05% & Ectoine 2.0%","genericName":"Hyaluronic acid 0.05% & Ectoine 2.0%","slug":"hyaluronic-acid-0-05-ectoine-2-0","indication":"Dry eye disease / Keratoconjunctivitis sicca","status":"marketed"}]}],"pipeline":[{"name":"Hyaluronic acid 0.05% & Ectoine 2.0%","genericName":"Hyaluronic acid 0.05% & Ectoine 2.0%","slug":"hyaluronic-acid-0-05-ectoine-2-0","phase":"marketed","mechanism":"Hyaluronic acid and ectoine work together to hydrate and protect the ocular surface by retaining moisture and stabilizing cell membranes against osmotic stress.","indications":["Dry eye disease / Keratoconjunctivitis sicca","Ocular surface protection and lubrication"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}